Iovance Biotherapeutics, Inc. Gains 31.48%
Tue, Sep 29, 2026 at 07:35 PM
Iovance Biotherapeutics, Inc. (IOVA:NASDAQ) jumped higher at $14.45, a gain of 31.5%. On Tue, Sep 29, 2026, IOVA:NASDAQ touched a New 2-Week High of $14.45. The stock appeared on our News Catalysts scanner on Tue, Sep 29, 2026 at 03:59 PM in the 'MISCELLANEOUS' category. From Tue, Sep 15, 2026, the stock recorded 70.00% Up Days and 72.73% Green Days
About Iovance Biotherapeutics, Inc. (IOVA:NASDAQ)
Lion Biotechnologies Inc is a biopharmaceutical company in the United States. Its lead pipeline candidate, LN-144, uses the tumor-infiltrating lymphocytes to treat serious diseases.
Top 10 Gainers:
- Decent Holding Inc. (DXST:NASDAQ), 55.9%
- SoundThinking, Inc. (SSTI:NASDAQ), 50.09%
- Masonglory Limited (MSGY:NASDAQ), 41.85%
- Sangoma Technologies Corporation (SANG:NASDAQ), 37.33%
- Bgin Blockchain Limited (BGIN:NASDAQ), 34.78%
- Profusa Inc. (PFSA:NASDAQ), 34.32%
- Iovance Biotherapeutics, Inc. (IOVA:NASDAQ), 31.48%
- OceanPal Inc. (SVRN:NASDAQ), 29.34%
- Silexion Therapeutics Corp (SLXN:NASDAQ), 28.18%
- E-Home Household Service Holdings Limited (EJH:NASDAQ), 27.39%